Chinese fund invests A$45 million into South Australian health and biotech industry

A Chinese fund has invested A$45 million to accelerate the development and commercialisation of translational health and medical research outcomes from South Australia. The investment will enable researchers from the University of Adelaide, University of South Australia, the state’s hospitals and other institutions to develop proof of concept, undertake clinical trials, and bring new drugs and technologies to the global market.

Leave a Reply

Your email address will not be published.